# Evaluation of Obex® in Overweight and Obesity

> **NCT03541005** · PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 160 (actual)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Obex
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03541005
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2021-07-03
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2021-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03541005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03541005, "Evaluation of Obex® in Overweight and Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03541005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*